KRT7 and adenocarcinoma: In morphologically determined pancreatobiliary-type adenocarcinomas (n = 67), most tumours (58 of 65) had diffuse CK7 expression (in >40% of the tumour cells) or were largely negative for MUC2 (62 of 65) and CDX2 (57 of 65).